Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?Stacy Loeb, Edward F Vonesh, E Jeffrey Metter, et al.The Prostate|August 13, 2013
PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressivenessMichael J Ahrens, Paul A Bertin, Edward F Vonesh, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2010
Assessing creatinine clearance from modification of diet in renal disease study equations in the ADEMEX cohort: limitations and potential applicationsJames A Sloand, John K Leypoldt, Bruce F Culleton, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 20, 2006
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammationMohamed Suliman, Peter Stenvinkel, Abdul Rashid Qureshi, et al.Head & Neck|January 19, 2007
Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancerCathy Lazarus, Jeri A Logemann, Barbara Roa Pauloski, et al.Head & Neck|December 4, 2003
Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropoutAlfred W Rademaker, Edward F Vonesh, Jeri A Logemann, et al.Journal of the American Society of Nephrology : JASN|July 12, 2019
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled TrialsLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.Journal of the American Society of Nephrology : JASN|July 12, 2019
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical SimulationTom Greene, Jian Ying, Edward F Vonesh, et al.Journal of the American Society of Nephrology : JASN|December 4, 2021
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease ProgressionBrendon L Neuen, Hocine Tighiouart, Hiddo J L Heerspink, et al.Pageof 2